BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 30832742)

  • 1. Personalized medicine with IgGAM compared with standard of care for treatment of peritonitis after infectious source control (the PEPPER trial): study protocol for a randomized controlled trial.
    Kalvelage C; Zacharowski K; Bauhofer A; Gockel U; Adamzik M; Nierhaus A; Kujath P; Eckmann C; Pletz MW; Bracht H; Simon TP; Winkler M; Kindgen-Milles D; Albertsmeier M; Weigand M; Ellger B; Ragaller M; Ullrich R; Marx G
    Trials; 2019 Mar; 20(1):156. PubMed ID: 30832742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of early IgM-enriched immunoglobulin vs polyvalent IgG administration in score-identified postcardiac surgical patients at high risk for sepsis.
    Pilz G; Appel R; Kreuzer E; Werdan K
    Chest; 1997 Feb; 111(2):419-26. PubMed ID: 9041991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EXCHANGE-2: investigating the efficacy of add-on plasma exchange as an adjunctive strategy against septic shock-a study protocol for a randomized, prospective, multicenter, open-label, controlled, parallel-group trial.
    David S; Bode C; Stahl K;
    Trials; 2023 Apr; 24(1):277. PubMed ID: 37061693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving outcomes of severe infections by multidrug-resistant pathogens with polyclonal IgM-enriched immunoglobulins.
    Giamarellos-Bourboulis EJ; Tziolos N; Routsi C; Katsenos C; Tsangaris I; Pneumatikos I; Vlachogiannis G; Theodorou V; Prekates A; Antypa E; Koulouras V; Kapravelos N; Gogos C; Antoniadou E; Mandragos K; Armaganidis A;
    Clin Microbiol Infect; 2016 Jun; 22(6):499-506. PubMed ID: 26850828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock.
    Kreymann KG; de Heer G; Nierhaus A; Kluge S
    Crit Care Med; 2007 Dec; 35(12):2677-85. PubMed ID: 18074464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentaglobin (immunoglobulin M-enriched immunoglobulin) as adjuvant therapy for premature and very low-birth-weight neonates with sepsis.
    Nassir KF; Al-Saddi YI; Abbas HM; Al Khames Aga QA; Al Khames Aga LA; Oudah AA
    Indian J Pharmacol; 2021; 53(5):364-370. PubMed ID: 34854404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
    Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
    Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
    Laupland KB; Kirkpatrick AW; Delaney A
    Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant treatment of mediastinitis with immunoglobins (Pentaglobin) after cardiac surgery (ATMI): study protocol.
    Eur J Surg Suppl; 1999; (584):85-100. PubMed ID: 10890241
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se).
    Zimmermann JB; Pinder N; Bruckner T; Lehmann M; Motsch J; Brenner T; Hoppe-Tichy T; Swoboda S; Weigand MA; Hofer S
    Trials; 2017 Nov; 18(1):530. PubMed ID: 29126416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the timing of administration of IgM and IgA enriched immunoglobulins in patients with severe sepsis and septic shock and the outcome: a retrospective analysis.
    Berlot G; Vassallo MC; Busetto N; Bianchi M; Zornada F; Rosato I; Tartamella F; Prisco L; Bigotto F; Bigolin T; Ferluga M; Batticci I; Michelone E; Borelli M; Viviani M; Tomasini A
    J Crit Care; 2012 Apr; 27(2):167-71. PubMed ID: 21737236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right Dose Right Now: bedside data-driven personalized antibiotic dosing in severe sepsis and septic shock - rationale and design of a multicenter randomized controlled superiority trial.
    Roggeveen LF; Fleuren LM; Guo T; Thoral P; de Grooth HJ; Swart EL; Klausch TLT; van der Voort PHJ; Girbes ARJ; Bosman RJ; Elbers PWG
    Trials; 2019 Dec; 20(1):745. PubMed ID: 31852491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
    van Schaik IN; van Geloven N; Bril V; Hartung HP; Lewis RA; Sobue G; Lawo JP; Mielke O; Cornblath DR; Merkies IS;
    Trials; 2016 Jul; 17(1):345. PubMed ID: 27455854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PROCalcitonin-based algorithm for antibiotic use in Acute Pancreatitis (PROCAP): study protocol for a randomised controlled trial.
    Siriwardena AK; Jegatheeswaran S; Mason JM; Baltatzis M; Chan A; Sheen AJ; O'Reilly D; Jamdar S; Deshpande R; de Liguori Carino N; Satyadas T; Qamruddin A; Hayden K; Parker MJ; Butler J; Rajai A; McIntyre B
    Trials; 2019 Jul; 20(1):463. PubMed ID: 31358032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of pentaglobin therapy on prognosis in patients with severe sepsis].
    Tuğrul S; Ozcan PE; Akinci O; Cağatay A; Cakar N; Esen F
    Ulus Travma Derg; 2001 Oct; 7(4):219-23. PubMed ID: 11705075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Intravenous Immunoglobulins in Sepsis Therapy-A Clinical View.
    Jarczak D; Kluge S; Nierhaus A
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32756325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of new immunoglobulin preparation, enriched in IgA and IgM (IgGAM)].
    Blatrix C; Israël J; Reinert P; Griscelli C; Steinbuch M
    Nouv Presse Med; 1976 May; 5(18):1193-5. PubMed ID: 58407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial.
    Bloos F; Trips E; Nierhaus A; Briegel J; Heyland DK; Jaschinski U; Moerer O; Weyland A; Marx G; Gründling M; Kluge S; Kaufmann I; Ott K; Quintel M; Jelschen F; Meybohm P; Rademacher S; Meier-Hellmann A; Utzolino S; Kaisers UX; Putensen C; Elke G; Ragaller M; Gerlach H; Ludewig K; Kiehntopf M; Bogatsch H; Engel C; Brunkhorst FM; Loeffler M; Reinhart K;
    JAMA Intern Med; 2016 Sep; 176(9):1266-76. PubMed ID: 27428731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Si-ni-tang (a Chinese herbal formula) for improving immunofunction in sepsis: study protocol for a pilot randomized controlled trial.
    Zeng R; Zheng Y; Fan R; Zhou G; Zhang Y; Mai S; Xie D; Weng Y; Du J; Han Y; Lai F
    Trials; 2019 Aug; 20(1):537. PubMed ID: 31462310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Properties of and information about a new preparation of immunoglobulins (IgGAM) enriched in IgA and IgM].
    Blatrix C; Thebault J; Steinbuch M
    Rev Fr Transfus Immunohematol; 1977 Sep; 20(3):419-26. PubMed ID: 918496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.